Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lipigon Pharmaceuticals AB | 3,569,999 | net | 21 May 2025 | tx 7+3,569,999 |
| Camurus AB | 95,173 | net | 10 Jun 2021 | tx 14+108,926−13,753 |
2 purchases reported after at least 12 months of silence — most recent on 21 May 2025.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2025 | PURCHASE | Lipigon Pharmaceuticals AB | 2,520,000 | 0.09 SEK | first after silence |
| 03 Jun 2024 | OTHER | Lipigon Pharmaceuticals AB | 150,000 | 0.20 SEK | |
| 03 Jun 2024 | OTHER | Lipigon Pharmaceuticals AB | 150,000 | 0.20 SEK | deriv |
| 13 Dec 2023 | OTHER | Lipigon Pharmaceuticals AB | 300,000 | 0.30 SEK | |
| 13 Dec 2023 | OTHER | Lipigon Pharmaceuticals AB | 300,000 | 0.30 SEK | deriv |
| 06 Apr 2023 | PURCHASE | Lipigon Pharmaceuticals AB | 49,999 | 3.50 SEK | |
| 29 Jun 2022 | PURCHASE | Lipigon Pharmaceuticals AB | 100,000 | 2.15 SEK | first after silence |
| 10 Jun 2021 | GRANT_AWARD | Camurus AB | 33,750 | 0.00 SEK | deriv |
| 03 Jun 2021 | OTHER | Camurus AB | 7,100 | 0.00 SEK | |
| 19 May 2021 | LENDING | Camurus AB | 7,100 | 0.00 SEK | |
| 19 May 2021 | OTHER | Camurus AB | 8,720 | 133.40 SEK | |
| 19 May 2021 | SALE | Camurus AB | 7,100 | 199.00 SEK | |
| 19 May 2021 | OTHER | Camurus AB | 8,000 | 0.00 SEK | deriv |
| 15 Dec 2020 | OTHER | Camurus AB | 5,882 | 0.00 SEK | deriv |
| 15 Dec 2020 | OTHER | Camurus AB | 6,411 | 153.90 SEK | |
| 15 Dec 2020 | SALE | Camurus AB | 6,650 | 182.22 SEK | |
| 03 Jun 2019 | PURCHASE | Camurus AB | 9,009 | 11.10 SEK | deriv |
| 25 Mar 2019 | PURCHASE | Camurus AB | 9,072 | 42.00 SEK | |
| 25 Mar 2019 | SALE | Camurus AB | 3 | 0.00 SEK | deriv |
| 28 May 2018 | PURCHASE | Camurus AB | 8,000 | 12.83 SEK | |
| 02 Jun 2017 | PURCHASE | Camurus AB | 5,882 | 17.00 SEK |